当前位置: X-MOL 学术Lancet HIV › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to Lancet HIV 2019; 6: e230-39.
The Lancet HIV ( IF 16.1 ) Pub Date : 2019-04-04 , DOI: 10.1016/s2352-3018(19)30107-9


Priddy FH, Lewis DJM, Gelderblom HC, et al. Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial. Lancet HIV 2019; 6: e230–39—In the Results text, the neutralisation of CAP45.2.00.G3 has been corrected to ID50 titres in reciprocal dilution, not concentrations in μg/mL. This correction was made on April 3, 2019.

中文翻译:

柳叶刀艾滋病毒更正2019; 6:e230-39。

Priddy FH,Lewis DJM,Gelderblom HC等。腺相关病毒载体免疫预防以预防健康成年人中的HIV:一项1期随机对照试验。柳叶刀艾滋病毒2019; 6:e230–39 —在结果文本中,CAP45.2.00.G3的中和作用已在相互稀释中校正为ID50滴度,而非在μg/ mL中的浓度。此更正是在2019年4月3日进行的。
更新日期:2019-12-03
down
wechat
bug